Real-world treatment patterns and survival outcomes in HER2-positive metastatic gastric cancer
tr (code pays fourni par la source)
0 citations
Akademik Gastroenteroloji Dergisi
Hatice Bölek
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
70Publications signalées
204Citations signalées
4Affiliations récentes
Les institutions déclarées
Les domaines associés
Renal cell carcinoma treatmentCancer Immunotherapy and BiomarkersProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentBladder and Urothelial Cancer Treatments
Les publications récentes
Prognostic impact of the Gustave Roussy Immune score in metastatic renal cell carcinoma treated with first-line immunotherapy-based combinations: results from the Turkish Oncology Group Kidney Cancer Consortium (TKCC)
Abdullah Akkuş, Hatice Bölek, Esma Kaplan Tüzün, Elif Sertesen Çamöz et autres
tr, kh, ag (code pays fourni par la source)
0 citations
BMC Cancer
Pretreatment HALP Score and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Tyrosine Kinase Inhibitors: A Turkish Oncology Group Kidney Cancer Consortium (TKCC) Study
Murat Günaltılı, Hatice Bölek, Esma Kaplan Tüzün, Sura Usta et autres
tr, us (code pays fourni par la source)
0 citations
Cancers
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression
Fabio Turco, Silke Gillessen, Giuseppe Salfi, Iris S. H. Kloots et autres
ch, nl, us, fr, it, jp, il, tr, es, be, au, gb (code pays fourni par la source)
0 citations
Prostate Cancer and Prostatic Diseases
Aspirin use and outcomes with immune checkpoint inhibitors in metastatic cancer.
Satı Coskun Yazgan, Nursima Kanburoglu, Beliz Bahar Karaoğlan, Hatice Bölek et autres
tr (code pays fourni par la source)
1 citation
Journal of Clinical Oncology
First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis
Mustafa Seyyar, Pervin Can Sanci, Abdullah Sakin, Ayberk Bayramgil et autres
tr (code pays fourni par la source)
0 citations
Medicina
Refining prognosis in advanced renal cell carcinoma: international real-world validation of the Meet-URO score in first-line immunotherapy combinations
Sara Elena Rebuzzi, Aruni Ghose, S. Rudman, Balaji Venugopal et autres
it, gb, cz, tr, hk, us (code pays fourni par la source)
1 citation
The Oncologist
Prognostic Impact of Intraductal Carcinoma in Patients with Metastatic Prostate Cancer Treated with Abiraterone Acetate or Enzalutamide
Hatice Bölek, Satı Coşkun Yazgan, Emre Yekedüz, Yüksel Ürün
tr (code pays fourni par la source)
0 citations
Bulletin of Urooncology
Comments on the LUNAR Trial in Oligorecurrent Hormone-Sensitive Prostate Cancer
tr (code pays fourni par la source)
0 citations
Journal of Clinical Oncology
Survival Outcomes and Prognostic Factors in Head and Neck Adenoid Cystic Carcinoma Following Curative Surgery
Hatice Bölek, Mehmet Kayaalp, Taha Koray Sahin, Osman Talha Doğan et autres
tr (code pays fourni par la source)
0 citations
Journal of Oncological Sciences
Prognostic role of smoking in metastatic renal cell carcinoma in real-world data from the Turkish Oncology Group Kidney Cancer Consortium (TKCC)
Hatice Bölek, Elif Sertesen Camoz, Omer F. Kuzu, Hilal Karakaş et autres
tr, us (code pays fourni par la source)
1 citation
Scientific Reports
Outcomes and prognostic markers in locally advanced head and neck squamous cell carcinoma underwent chemoradiotherapy
Hatice Bölek, Mehmet Kayaalp, Y. Babayigit, Sümerya Duru Birgi et autres
tr (code pays fourni par la source)
0 citations
Discover Oncology
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.